Search

Search Constraints

You searched for: Author/Creator Champlin, Richard

Search Results

31. Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit. (March 2018)

32. Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma. (14th March 2017)

33. Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia. Issue 11 (12th August 2020)

34. Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia. Issue 3 (March 2014)

35. Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant. (6th September 2022)

36. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. Issue 2 (26th February 2021)

37. Predictors of inferior clinical outcome in patients with standard‐risk multiple myeloma. (1st December 2016)

38. Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. Issue 2 (11th December 2022)

39. Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. (8th April 2021)

40. Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia. Issue 15 (30th April 2013)